Crossmark

Good clinical trial funding practices: how can public funders reduce the risk of trial failure and improve health impact?

Crossref DOI link: https://doi.org/10.1186/s13063-026-09511-y

Published Online: 2026-02-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hulstaert, Frank https://orcid.org/0000-0003-2879-9910
Harrison, Jillian https://orcid.org/0000-0002-5024-1422
Nevens, Hilde https://orcid.org/0000-0001-6507-8632
Stocquart, Nelle https://orcid.org/0000-0002-0263-3552
Marynen, Elisabeth https://orcid.org/0009-0009-2552-5333
Pouppez, Céline https://orcid.org/0000-0002-5317-8967
Neyt, Mattias https://orcid.org/0000-0002-9593-3887
Verleye, Leen https://orcid.org/0000-0003-4528-1873
Vrijens, France https://orcid.org/0000-0002-8744-6499
License Information

Text and Data Mining valid from 2026-02-04

Version of Record valid from 2026-03-06
More Information

Article History

Received: 29 October 2025

Accepted: 28 January 2026

First Online: 4 February 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.